ANNOUNCEMENTS:

Stay Up-To-Date with office hours and info. TEXT “allergyct” TO 833-300-4888. EARLY CLOSURE 1 PM ON MONDAY 12/2/19.

EpiPen

FDA alerts consumers of nationwide voluntary recall of EpiPen and EpiPen Jr

The U.S. Food and Drug Administration is alerting consumers to Meridian Medical Technologies’ voluntary recall of 13 lots of Mylan’s EpiPen and EpiPen Jr (epinephrine injection) Auto-Injector products used for emergency treatment of severe allergic reactions. This recall is due to the potential that these devices may contain a defective part that may result in the devices’ …

FDA alerts consumers of nationwide voluntary recall of EpiPen and EpiPen Jr Read More »

eczema

FDA approves dupilumab for moderate to severe eczema

“Sanofi and Regeneron Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved Dupixent® (dupilumab) Injection, the first and only biologic medicine approved for the treatment of adults with moderate-to-severe atopic dermatitis (AD) whose disease is not adequately controlled with topical prescription therapies, or when those therapies are not advisable.” After much …

FDA approves dupilumab for moderate to severe eczema Read More »

fish oil

Fish oil supplementation during pregnancy may lower asthma risk

Preventing allergy is a priority for both physicians and parents. There have been many studies attempting to lessen the risk of both food and environmental allergies. Here are a few examples of possible interventions to decrease the risk of allergy; Frequent application of emollients (moisturizers) from birth. Breast feeding, hypoallergenic formulas, early introduction of foods. Probiotics. …

Fish oil supplementation during pregnancy may lower asthma risk Read More »